Converge Bio
Converge Bio integrates Generative AI with biological data. Converge Bio's mission is to empower biotech and pharmaceutical companies to discover and develop more effective drugs faster, utilizing the power of LLMs specifically trained on biological languages.
Converge Bio is active in the ai & ml space based in United States, founded in 2024.
Converge Bio is positioned in ai & ml, a segment that rewards a clear, focused offering.
Its base of operations is United States.
The company is listed at the Bessemer portfolio company stage of development.
| Sector | AI & ML |
|---|---|
| Country | United States |
| Founded | 2024 |
| Stage | Bessemer portfolio company |
Website: converge-bio.com
Full contact details are available to registered Pixilab members.
Create a free account
Create a free account